by Adam Mayers November 11, 2019 Number of comments0 Emerging Markets Featured Post Healthcare Amgen bets on growth in China U.S. biotech company Amgen is investing U.S. $2.7 billion in the Chinese firm Beigene.
Adam Mayers 